Results 21 to 30 of about 20,811 (229)

Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events (Review) [PDF]

open access: yes, 2009
Background Epidemiological evidence has suggested a link between beta2-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are ...
Cates, CJ, Jaeschke, R, Lasserson, TJ
core   +1 more source

An update on the use of indacaterol in patients with COPD

open access: yesTherapeutic Advances in Respiratory Disease, 2011
Current guidelines for the management of chronic obstructive pulmonary disease (COPD) establish that bronchodilator medications are central to the symptomatic treatment of the disease.
Nadia S. Brienza   +2 more
doaj   +1 more source

Investigation of the assortment of medicines for the treatment of chronic obstructive pulmonary disease in the pharmaceutical market of Ukraine

open access: yesAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2020
The aim of the work – to analyze the assortment of medicines for the treatment of chronic obstructive pulmonary disease (COPD) (bronchodilator therapy (BT). in the modern pharmaceutical market of Ukraine. Materials and Methods.
L. I. Budniak , Ye. Yu. Dynia
doaj   +1 more source

Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. [PDF]

open access: yes, 2014
BACKGROUND: Inhaled corticosteroids (ICS) are anti-inflammatory drugs that have proven benefits for people with worsening symptoms of chronic obstructive pulmonary disease (COPD) and repeated exacerbations.
Agarwal   +163 more
core   +1 more source

Adherence to Inhalation Devices in Patients with Chronic Obstructive Pulmonary Disease

open access: yesPatient Preference and Adherence, 2023
Luis Fernando Valladales-Restrepo,1– 3 María Camila Oyuela-Gutiérrez,3 Ana Camila Delgado-Araujo,1 Juliana Calvo-Salazar,1 Daniel Osorio-Bustamante,3 Cesar Eduardo Lerma-Barco,3 Jorge Enrique Machado-Alba1 1Grupo de Investigación en Farmacoepidemiología ...
Valladales-Restrepo LF   +6 more
doaj  

The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD : current evidence and future prospects [PDF]

open access: yes, 2019
Long-acting bronchodilators are the cornerstone of pharmacologic treatment of chronic obstructive pulmonary disease (COPD). Spiolto (R) or Stiolto (R) is a fixed-dose combination (FDC) containing two long-acting bronchodilators, the long-acting ...
Brusselle, Guy, Derom, Eric, Joos, Guy
core   +1 more source

Calcium and potassium channels are involved in curcumin relaxant effect on tracheal smooth muscles

open access: yesPharmaceutical Biology, 2020
Context Curcumin, the active component of Curcuma longa L. (Zingiberaceae), exhibits a wide variety of biological activities including vasodilation and anti-inflammation.
Bahman Emami   +7 more
doaj   +1 more source

The clinical effectiveness and cost-effectiveness of inhaler devices used in the routine management of chronic asthma in older children: a systematic review and economic evaluation [PDF]

open access: yes, 2002
Background: This review examines the clinical effectiveness and cost-effectiveness of hand-held inhalers to deliver medication for the routine management of chronic asthma in children aged between 5 and 15 years.
Beverley, C.   +4 more
core   +1 more source

Overprescription of short-acting β2 agonists: reflections from the SABINA study in Brazil

open access: yesJornal Brasileiro de Pneumologia
Objective: To assess prescription patterns for short-acting b2 agonists (SABAs) and other asthma medications in asthma patients treated by specialists and participating in the SABA use IN Asthma (SABINA) study in Brazil.
Martti Anton Antila   +7 more
doaj   +2 more sources

COPD and glycopyrronium responsiveness assessment: An appraisal

open access: yesLung India, 2023
Clinical Trial Registration: ECR/159/Inst/WB/2013/RR-20 Background: Glycopyrronium bromide (a long-acting antimuscarinic agent: LAMA) appears pharmacokinetically suitable for testing bronchodilator responsiveness as salbutamol (short-acting β2-agonist ...
Parthasarathi Bhattacharyya   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy